IIL presents selected technology projects to investors whose mandate, risk tolerance, sector experience and capital profile may fit a specific opportunity. The portfolio is not offered as one undifferentiated fund. Each project has its own ownership, evidence base, development pathway, capital requirement and route to value.
What investors can explore
- Independent MedTech, BioTech, DeepTech, healthcare, advanced-materials and sustainability projects.
- Equity, co-investment, joint-venture, project-finance, licensing or other structures where legally and commercially appropriate.
- Project-specific diligence, milestone plans, commercial assumptions and risk registers under controlled disclosure.
- A London platform for structuring international execution, partners and market access.
How access works
- Review the non-confidential portfolio and state your mandate.
- Confirm sector, geography, ticket range, stage and decision process.
- Execute the appropriate confidentiality and eligibility documentation.
- Receive a project-specific information pack and diligence pathway.
- Discuss structure only after key facts, gaps and dependencies are visible.
Investor fit comes before disclosure.
IIL does not circulate detailed technical or financial materials indiscriminately. The objective is to establish whether there is a credible fit before either side commits significant time or exposes sensitive information.
Non-confidential overview
Additive Manufacturing Competence Centre
The competence-centre concept combines equipment, central expertise, methods, training, documentation and an operating model.
Review opportunityNon-confidential overview
Advanced Fire-Protection Materials
The opportunity concerns advanced fire-protection materials and application know-how subject to performance, certification and manufacturing diligence.
Review opportunityNon-confidential overview
AI Cardiology Technology Opportunity
AI-supported cardiology may improve analysis or workflow, but value depends on data quality, validation, integration and accountable clinical use.
Review opportunityNon-confidential overview
Artificial Blood and Blood-Substitute Technology
This is an investigational life-science opportunity; public information must not be interpreted as evidence of safety, efficacy or approval.
Review opportunityNon-confidential overview
Artificial Skin and Advanced Wound-Care Opportunity
The opportunity concerns technologies intended to support wound protection, tissue management and advanced care pathways.
Review opportunityNon-confidential overview
Biosignal and Bioresonance Technology Opportunity
Claims in this field require particularly careful scientific and regulatory scrutiny. Public description indicates an area of investigation, not validated diagnosis or treatment.
Review opportunityNon-confidential overview
Healthcare AI Commercialisation Portfolio
A portfolio view can reveal reusable data, validation and deployment capability, but each use case needs its own intended use and evidence.
Review opportunityNon-confidential overview
Lipid Delivery Platform for Medicines and Nutrients
The IIL-managed concept uses lipid-based carriers for medicines, vitamins, minerals or other active substances and is described publicly only at category level.
Review opportunityNon-confidential overview
MaviVital Multisensory Medical Monitor
MaviVital is presented as a multisensory medical-monitor opportunity subject to detailed technical, regulatory and commercial diligence.
Review opportunityNon-confidential overview
Medical-Device Manufacturing Transfer
A medical-device manufacturing transfer requires design control, supplier control, validated process, quality agreements and regulatory responsibility.
Review opportunityNon-confidential overview
Waste-to-Energy Technology Opportunity
A waste-to-energy technology must be evaluated as a site-specific technical, environmental and commercial system.
Review opportunityNon-confidential overview
Wave-Based Oncology Research Technology
This is a research-stage oncology concept. Nothing on the public page is a treatment claim or substitute for established cancer care.
Review opportunity